MedPath

A single-center non-blinded randomized controlled trial on the effect of ovarian hyperstimulation on endometrial receptivity

Conditions
subfertility
10013356
Registration Number
NL-OMON38364
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
193
Inclusion Criteria

All couples that present to one of the participating centers for their first IVF/ICSI treatment.

Exclusion Criteria

1.Women younger than 18 and older than 38year
2. Couples undergoing a PGD cycle.
3. Couples for which IVF/ICSI is used to prevent the transmission of HIV.
4. Couples undergoing a modified natural cycle.
5. Couples undergoing IVF/ICSI with surgically retrieved spermatozoa.
6. Women with borderline or invasive ovarian cancer.
7. Women with contraindications for IVF/ICSI treatment such as cardiovascular-pulmonary
disease, severe diabetes, bleeding disorders, immunodeficiency and morbid obesity
8. Women with premature ovarian failure.
9. Women with severe psychopathology, severe anxiety and inability to cope with treatment.
10. Not able or willing to provide informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Ongoing pregnancy defined by the presence of a viable intra-uterine pregnancy<br /><br>at 12 weeks of gestation.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcomes are embryo quality, implantation rate, biochemical<br /><br>pregnancy, clinical pregnancy, multiple pregnancies, live birth, time to<br /><br>pregnancy, health of babies born and costs. </p><br>
© Copyright 2025. All Rights Reserved by MedPath